Cultivated Bio-Materials

Design working formulations before your first batch

Celleste charts the formulation space for lab-grown materials and forecasts which recipes can perform before you commit to a batch. Get a validated sample in months, not years.

The Problem

Bio-material iterations often fail for reasons visible only afterward

Materials scientists creating lab-grown materials often run 40 to 80 batch iterations before finding a working formulation. Every failed batch takes weeks and uses costly precursors. Without composition-based performance predictions, each batch becomes a high-stakes guess.

40-80
average iterations before a validated sample
2-4 years
usual timeline for developing a new bio-material formulation
How It Works

Turn composition data into candidate formulations in a workflow

Add your material data

Bring in batch records, literature values, or pilot measurements. Celleste takes in composition variables together with their measured properties.

Create candidate formulations

Celleste explores your composition space and suggests formulations expected to meet your target properties, ordered by predicted performance.

Predict before batching

For every candidate, Celleste provides predicted tensile strength, biodegradation rate, and cell adhesion profile with confidence intervals. Run only formulations worth testing.

Capabilities

Three ways Celleste supports materials scientists

Generate formulations

Using your target property profile and lab composition variables, Celleste creates a ranked set of candidate recipes. No guessing from a blank slate.

Predict properties

Use composition inputs alone to predict tensile strength, elongation at break, cell adhesion score, and biodegradation rate. See the performance profile before running the batch.

Track iterations

Record predicted and actual results over time. As your lab gathers real batch data, Celleste sharpens its predictions and connects prediction with experiment.

Early Results

Results from our internal pilot

Across 3 bio-material development cycles in our internal pilot, average iterations to a validated sample fell from 62 to 11.

Source: internal pilot data, early-access program, 2025. Bootstrapped-stage pilot, not enterprise-scale claim.

Celleste reshaped our formulation process. We once relied on intuition, then iterated until a result worked. Now we begin with ranked candidates and predicted properties. We still run batches, but we run fewer.

Dr. Maya Ohayon, Materials Scientist

composite bio-materials lab, early-access program participant

Begin with your formulation challenge

Test Celleste with material data. The Pilot plan is free with no time limit.